BofA analyst Jason Gerberry raised the firm’s price target on Arrowhead to $37 from $29 and keeps a Buy rating on the shares. The analyst now assigns Arrowhead full credit for net cash to reflect flexibility the company has to limit cash burn in 2024. The firm says Arrowhead offers attractive risk/reward heading into 2024 “de-risking catalysts.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ARWR:
- Arrowhead applies for clearance to begin Phase 1/2a trial of RNAi therapeutic
- Bank of America Says the S&P 500 Will Hit a New Record High in 2024 — Here Are 2 Stocks to Play That Bullish Sentiment
- Biotech Alert: Searches spiking for these stocks today
- GM upgraded, Lululemon downgraded: Wall Street’s top analyst calls
- Arrowhead initiated with a Buy, $29 price target at BofA
